Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston Children's Hospital
Research
Sickle cell gene therapy process may cause cancerous mutations
A study on patients in a clinical trial for sickle cell disease suggests a pre-treatment process might cause cancerous mutations in blood stem cells.
Helen Floersh
Nov 20, 2023 9:10am
Chronic pain pathway linked to lung cancer
Sep 1, 2022 9:15am
ElevateBio, Boston Children's Hospital collab on new CAR-T biz
Aug 4, 2022 11:00am
Study of dogs and cats sheds light on key immune pathways
Aug 6, 2021 2:00pm
Attacking pancreatic cancer with an I-O drug conjugate
Nov 9, 2020 8:31am
CRISPR slows the growth of triple-negative breast cancer in mice
Aug 26, 2019 3:00pm
